Potential One-time Gene Therapy for Parkinson’s Linked to GBA Mutations to Enter Clinical Trial
A potential gene therapy for Parkinson’s disease associated with mutations in the GBA1 gene, PR001, will move into…
Articles by Alejandra Viviescas, PhD
Vitamin B12 May Protect Nerve Cells From Alpha-synuclein Clumps, Study Suggests
Vitamin B12 can prevent the formation of and destroy alpha-synuclein aggregates in the brain, lowering their toxicity and potentially…
Gocovri Leads to Steady ‘On’ States in Parkinson’s Patients, Phase 3 Pooled Data Suggest
Gocovri (amantadine) can effectively reduce the number and duration of “off” periods and dyskinesia (uncontrolled movement) episodes in…
Trace Amines Potential Biomarkers for Early Parkinson’s and Disease Progression, Study Suggests
Trace amines, the product of the metabolism of specific amino acids, could indicate changes that occur early during Parkinson’s disease…
High-frequency Brain Stimulation Is Superior for Parkinson’s Patients, Study Suggests
Repetitive transcranial magnetic stimulation (rTMS), given at high or low frequency, effectively reduces motor symptoms in Parkinson’s disease patients,…
Stem Cell Transplants Could Significantly Improve Parkinson’s Treatment, Study Suggests
Cell replacement therapies in which dopamine-producing stem cells are transplanted into Parkinson’s disease patients could improve motor symptoms, reducing or eliminating…
New Diagnostics for PD Might Allow Early Diagnosis, Prevention
A new way of diagnosing Parkinson’s disease based on manifestations that appear decades before motor symptoms — the current hallmarks…